Stanniocalcin 2 improved osteoblast differentiation via phosphorylation of ERK

Mol Med Rep. 2016 Dec;14(6):5653-5659. doi: 10.3892/mmr.2016.5951. Epub 2016 Nov 16.

Abstract

Mammalian stanniocalcin 2 (STC2) is a glycoprotein hormone with multiple functions. The present study determined the importance of STC2 in osteoblast differentiation. It was revealed that the expression of STC2 was increased during the differentiation of MC3T3-E1 cells to osteoblasts and that knockdown of STC2 reduced osteoblast differentiation and mineralization, whereas STC2 overexpression increased differentiation and mineralization. Knockdown of STC2 downregulated the expression of osteoblast-associated genes, including runt‑related transcription factor 2, collagen type I α 1 chain, osterix and osteocalcin. Overexpression of STC2 upregulated the expression of these osteoblastic genes. In addition, overexpression of STC2 enhanced the phosphorylation of extracellular signal‑regulated kinase 1/2 (ERK1/2), whereas inhibition of ERK phosphorylation reduced osteoblast differentiation of MC3T3‑E1 cells overexpressing STC2. These findings indicated that STC2 may promote osteoblast differentiation and mineralization by regulating ERK activation.

MeSH terms

  • Animals
  • Calcification, Physiologic / genetics
  • Cell Differentiation* / genetics
  • Cell Line
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Gene Expression
  • Gene Knockdown Techniques
  • Glycoproteins / genetics
  • Glycoproteins / metabolism*
  • Intercellular Signaling Peptides and Proteins
  • Intracellular Signaling Peptides and Proteins
  • Mice
  • Organ Specificity / genetics
  • Osteoblasts / cytology*
  • Osteoblasts / metabolism*
  • Phosphorylation

Substances

  • Glycoproteins
  • Intercellular Signaling Peptides and Proteins
  • Intracellular Signaling Peptides and Proteins
  • Stc2 protein, mouse
  • Extracellular Signal-Regulated MAP Kinases